These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 723796)

  • 41. Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
    Cornwell GG; Pajak TF; Kochwa S; McIntyre OR; Glowienka LP; Brunner K; Rafla S; Silver RT; Cooper MR; Henderson E; Kyle RA; Haurani FI; Cuttner J
    Cancer; 1982 Nov; 50(9):1669-75. PubMed ID: 7116299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
    Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
    J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Some preliminary observations on chemotherapy of infantile medulloblastomas with vincristine sulfate and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)].
    Pompili A; Cianfriglia F; Occhipinti E
    Minerva Pediatr; 1978 Nov; 30(21):1721-4. PubMed ID: 723818
    [No Abstract]   [Full Text] [Related]  

  • 45. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Postoperative treatment of malignant glial tumors of the brain with CCNU].
    Pomodanov AP; Sosnov IuD; Perevodchikova NI; Dvoĭrin VV; Assekritova IV
    Vestn Akad Med Nauk SSSR; 1981; (11):667-72. PubMed ID: 6275625
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CCNU in brain tumours.
    Garrett MJ; Hughes HJ; Ryall RD
    Clin Radiol; 1975 Apr; 26(2):183-4. PubMed ID: 1149380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report.
    Packer RJ; Siegel KR; Sutton LN; Evans AE; D'Angio G; Rorke LB; Bunin GR; Schut L
    Ann Neurol; 1988 Oct; 24(4):503-8. PubMed ID: 3239953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
    Hildebrand J; Gangji D; Nouwynck C; Machin D
    Cancer Treat Rep; 1977 Dec; 61(9):1695-8. PubMed ID: 74284
    [No Abstract]   [Full Text] [Related]  

  • 52. CCNU overdose during PCV chemotherapy for anaplastic astrocytoma.
    Abele M; Leonhardt M; Dichgans J; Weller M
    J Neurol; 1998 Apr; 245(4):236-8. PubMed ID: 9591226
    [No Abstract]   [Full Text] [Related]  

  • 53. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of some intracranial tumors in children and adults.
    Bloom HJ
    Prog Clin Biol Res; 1978; 25():55-84. PubMed ID: 216024
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
    [No Abstract]   [Full Text] [Related]  

  • 59. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy dose-intensity and survival for childhood medulloblastoma.
    Smith RL; Shi X; Estlin EJ
    Anticancer Res; 2012 Sep; 32(9):3885-92. PubMed ID: 22993333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.